

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | intestinal absorption (GO:0050892) | 8.23941878 |
| 2 | daunorubicin metabolic process (GO:0044597) | 6.88802220 |
| 3 | polyketide metabolic process (GO:0030638) | 6.88802220 |
| 4 | doxorubicin metabolic process (GO:0044598) | 6.88802220 |
| 5 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 6.54546082 |
| 6 | intestinal epithelial cell development (GO:0060576) | 6.37548243 |
| 7 | intestinal cholesterol absorption (GO:0030299) | 6.26924761 |
| 8 | aminoglycoside antibiotic metabolic process (GO:0030647) | 6.07986106 |
| 9 | regulation of respiratory burst (GO:0060263) | 5.98342834 |
| 10 | cellular glucuronidation (GO:0052695) | 5.39953468 |
| 11 | complement activation, classical pathway (GO:0006958) | 5.33058539 |
| 12 | ethanol oxidation (GO:0006069) | 5.29387672 |
| 13 | glucuronate metabolic process (GO:0019585) | 5.25779570 |
| 14 | uronic acid metabolic process (GO:0006063) | 5.25779570 |
| 15 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 5.21524812 |
| 16 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 5.05366161 |
| 17 | angiotensin maturation (GO:0002003) | 4.90036066 |
| 18 | L-phenylalanine metabolic process (GO:0006558) | 4.89757942 |
| 19 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.89757942 |
| 20 | regulation of chemokine secretion (GO:0090196) | 4.89015255 |
| 21 | antibacterial humoral response (GO:0019731) | 4.84306607 |
| 22 | regulation of protein activation cascade (GO:2000257) | 4.83639743 |
| 23 | digestive system process (GO:0022600) | 4.83579470 |
| 24 | hepatocyte apoptotic process (GO:0097284) | 4.82257972 |
| 25 | antimicrobial humoral response (GO:0019730) | 4.77216843 |
| 26 | regulation of complement activation (GO:0030449) | 4.70285123 |
| 27 | ribosomal small subunit assembly (GO:0000028) | 4.65190247 |
| 28 | epoxygenase P450 pathway (GO:0019373) | 4.59835542 |
| 29 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.53608852 |
| 30 | L-phenylalanine catabolic process (GO:0006559) | 4.53608852 |
| 31 | complement activation (GO:0006956) | 4.51178812 |
| 32 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 4.44616627 |
| 33 | flavonoid metabolic process (GO:0009812) | 4.44055595 |
| 34 | regulation of bile acid biosynthetic process (GO:0070857) | 4.42996684 |
| 35 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.39283596 |
| 36 | proline biosynthetic process (GO:0006561) | 4.37930764 |
| 37 | maintenance of gastrointestinal epithelium (GO:0030277) | 4.35953848 |
| 38 | acute-phase response (GO:0006953) | 4.34823816 |
| 39 | complement activation, alternative pathway (GO:0006957) | 4.32047507 |
| 40 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.25297842 |
| 41 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 4.24945302 |
| 42 | GDP-mannose metabolic process (GO:0019673) | 4.22152150 |
| 43 | viral transcription (GO:0019083) | 4.21107269 |
| 44 | protein activation cascade (GO:0072376) | 4.16275317 |
| 45 | urea metabolic process (GO:0019627) | 4.12382887 |
| 46 | negative regulation of keratinocyte proliferation (GO:0010839) | 4.07265797 |
| 47 | glycoside metabolic process (GO:0016137) | 4.06968923 |
| 48 | actin filament depolymerization (GO:0030042) | 4.04887808 |
| 49 | translational termination (GO:0006415) | 4.04827655 |
| 50 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 4.04757958 |
| 51 | urea cycle (GO:0000050) | 4.02824321 |
| 52 | desmosome organization (GO:0002934) | 4.01200598 |
| 53 | vitamin A metabolic process (GO:0006776) | 3.99117717 |
| 54 | virion attachment to host cell (GO:0019062) | 3.98515889 |
| 55 | adhesion of symbiont to host cell (GO:0044650) | 3.98515889 |
| 56 | interferon-gamma secretion (GO:0072643) | 3.96472609 |
| 57 | membrane repolarization during action potential (GO:0086011) | 3.95953623 |
| 58 | regulation of cholesterol homeostasis (GO:2000188) | 3.95293152 |
| 59 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.93312800 |
| 60 | bile acid and bile salt transport (GO:0015721) | 3.93212340 |
| 61 | hemidesmosome assembly (GO:0031581) | 3.91786367 |
| 62 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.87918152 |
| 63 | ATP synthesis coupled proton transport (GO:0015986) | 3.87918152 |
| 64 | phenylpropanoid metabolic process (GO:0009698) | 3.86966097 |
| 65 | regulation of cellular extravasation (GO:0002691) | 3.84839364 |
| 66 | negative regulation of epidermal cell differentiation (GO:0045605) | 3.82766369 |
| 67 | ribosomal large subunit biogenesis (GO:0042273) | 3.81955179 |
| 68 | drug metabolic process (GO:0017144) | 3.81263328 |
| 69 | O-glycan processing (GO:0016266) | 3.80099325 |
| 70 | bile acid metabolic process (GO:0008206) | 3.78453091 |
| 71 | opsonization (GO:0008228) | 3.78158063 |
| 72 | endocrine pancreas development (GO:0031018) | 3.77414000 |
| 73 | tight junction assembly (GO:0070830) | 3.71628686 |
| 74 | ethanol metabolic process (GO:0006067) | 3.71380426 |
| 75 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.71009146 |
| 76 | protein-lipid complex remodeling (GO:0034368) | 3.70422200 |
| 77 | macromolecular complex remodeling (GO:0034367) | 3.70422200 |
| 78 | plasma lipoprotein particle remodeling (GO:0034369) | 3.70422200 |
| 79 | nitrogen cycle metabolic process (GO:0071941) | 3.70108080 |
| 80 | primary alcohol catabolic process (GO:0034310) | 3.68897858 |
| 81 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.68408878 |
| 82 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.68408878 |
| 83 | arginine metabolic process (GO:0006525) | 3.64764947 |
| 84 | exogenous drug catabolic process (GO:0042738) | 3.63818998 |
| 85 | regulation of cholesterol esterification (GO:0010872) | 3.63664481 |
| 86 | protein targeting to ER (GO:0045047) | 3.63482028 |
| 87 | regulation of fibrinolysis (GO:0051917) | 3.61255632 |
| 88 | cotranslational protein targeting to membrane (GO:0006613) | 3.60880432 |
| 89 | protein carboxylation (GO:0018214) | 3.60190029 |
| 90 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.60190029 |
| 91 | plasma lipoprotein particle assembly (GO:0034377) | 3.59436116 |
| 92 | acute inflammatory response (GO:0002526) | 3.59352568 |
| 93 | low-density lipoprotein particle remodeling (GO:0034374) | 3.58504241 |
| 94 | negative regulation of fibrinolysis (GO:0051918) | 3.53030928 |
| 95 | primary alcohol metabolic process (GO:0034308) | 3.50608389 |
| 96 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.50126878 |
| 97 | maturation of SSU-rRNA (GO:0030490) | 3.47883500 |
| 98 | defense response to fungus (GO:0050832) | 3.47825217 |
| 99 | innate immune response in mucosa (GO:0002227) | 3.46539086 |
| 100 | cell differentiation involved in embryonic placenta development (GO:0060706) | 3.45584615 |
| 101 | translational elongation (GO:0006414) | 3.44780780 |
| 102 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.44126376 |
| 103 | positive regulation of digestive system process (GO:0060456) | 3.42795171 |
| 104 | keratinocyte proliferation (GO:0043616) | 3.41402460 |
| 105 | progesterone metabolic process (GO:0042448) | 3.39292105 |
| 106 | protein localization to endoplasmic reticulum (GO:0070972) | 3.38762107 |
| 107 | viral life cycle (GO:0019058) | 3.38612577 |
| 108 | cellular protein complex disassembly (GO:0043624) | 3.37508870 |
| 109 | negative regulation of protein activation cascade (GO:2000258) | 3.35532768 |
| 110 | retinal metabolic process (GO:0042574) | 3.33224624 |
| 111 | ribosomal small subunit biogenesis (GO:0042274) | 3.32858193 |
| 112 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.31793762 |
| 113 | sulfation (GO:0051923) | 3.31058493 |
| 114 | regulation of triglyceride catabolic process (GO:0010896) | 3.30678632 |
| 115 | glandular epithelial cell differentiation (GO:0002067) | 3.30414795 |
| 116 | high-density lipoprotein particle remodeling (GO:0034375) | 3.29792645 |
| 117 | positive regulation of chemokine secretion (GO:0090197) | 3.29409810 |
| 118 | plasma lipoprotein particle organization (GO:0071827) | 3.28601157 |
| 119 | thyroid hormone metabolic process (GO:0042403) | 3.28331736 |
| 120 | drug transmembrane transport (GO:0006855) | 3.27592985 |
| 121 | vitamin transmembrane transport (GO:0035461) | 3.26669980 |
| 122 | protein autoprocessing (GO:0016540) | 3.25787097 |
| 123 | trophectodermal cell differentiation (GO:0001829) | 3.21113518 |
| 124 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.20498447 |
| 125 | regulation of keratinocyte proliferation (GO:0010837) | 3.19352411 |
| 126 | purine nucleotide salvage (GO:0032261) | 3.18080547 |
| 127 | phospholipid efflux (GO:0033700) | 3.17764777 |
| 128 | transcytosis (GO:0045056) | 3.17662581 |
| 129 | protein-lipid complex assembly (GO:0065005) | 3.17545451 |
| 130 | cholesterol efflux (GO:0033344) | 3.16560497 |
| 131 | epithelial structure maintenance (GO:0010669) | 3.14586941 |
| 132 | negative regulation of sterol transport (GO:0032372) | 3.14363718 |
| 133 | negative regulation of cholesterol transport (GO:0032375) | 3.14363718 |
| 134 | positive regulation of epidermal cell differentiation (GO:0045606) | 3.12052444 |
| 135 | digestion (GO:0007586) | 3.12047222 |
| 136 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.09733154 |
| 137 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.09733154 |
| 138 | drug catabolic process (GO:0042737) | 3.08294953 |
| 139 | protein-lipid complex subunit organization (GO:0071825) | 3.07620489 |
| 140 | regulation of metalloenzyme activity (GO:0048552) | 3.07201330 |
| 141 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.07169179 |
| 142 | NADH metabolic process (GO:0006734) | 3.06903397 |
| 143 | proline metabolic process (GO:0006560) | 3.06027252 |
| 144 | adhesion of symbiont to host (GO:0044406) | 3.05285421 |
| 145 | phospholipid scrambling (GO:0017121) | 3.04599077 |
| 146 | diol metabolic process (GO:0034311) | 3.03722144 |
| 147 | cytidine deamination (GO:0009972) | 3.03207610 |
| 148 | cytidine metabolic process (GO:0046087) | 3.03207610 |
| 149 | cytidine catabolic process (GO:0006216) | 3.03207610 |
| 150 | arginine catabolic process (GO:0006527) | 3.02580493 |
| 151 | positive regulation of respiratory burst (GO:0060267) | 3.00186207 |
| 152 | negative regulation of complement activation (GO:0045916) | 2.99450434 |
| 153 | transepithelial transport (GO:0070633) | 2.99418410 |
| 154 | drug transport (GO:0015893) | 2.99408272 |
| 155 | modified amino acid transport (GO:0072337) | 2.99032155 |
| 156 | quinone metabolic process (GO:1901661) | 2.98863395 |
| 157 | regulation of viral release from host cell (GO:1902186) | 2.98461275 |
| 158 | mucosal immune response (GO:0002385) | 2.98447736 |
| 159 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.97956409 |
| 160 | respiratory electron transport chain (GO:0022904) | 2.97840349 |
| 161 | cardiovascular system development (GO:0072358) | 2.97575493 |
| 162 | regulation of apoptotic cell clearance (GO:2000425) | 2.97146951 |
| 163 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.97080741 |
| 164 | glucose 6-phosphate metabolic process (GO:0051156) | 2.96747190 |
| 165 | glutathione derivative biosynthetic process (GO:1901687) | 2.96090432 |
| 166 | glutathione derivative metabolic process (GO:1901685) | 2.96090432 |
| 167 | negative regulation of coagulation (GO:0050819) | 2.95974473 |
| 168 | negative regulation of glial cell proliferation (GO:0060253) | 2.94716136 |
| 169 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.94451760 |
| 170 | reverse cholesterol transport (GO:0043691) | 2.92419496 |
| 171 | electron transport chain (GO:0022900) | 2.92251349 |
| 172 | aromatic amino acid family catabolic process (GO:0009074) | 2.91681503 |
| 173 | positive regulation of lipid catabolic process (GO:0050996) | 2.91003119 |
| 174 | negative regulation of blood coagulation (GO:0030195) | 2.90872917 |
| 175 | negative regulation of hemostasis (GO:1900047) | 2.90872917 |
| 176 | translational initiation (GO:0006413) | 2.89437772 |
| 177 | diacylglycerol metabolic process (GO:0046339) | 2.89300191 |
| 178 | lung secretory cell differentiation (GO:0061140) | 2.89135659 |
| 179 | cellular aldehyde metabolic process (GO:0006081) | 2.88886231 |
| 180 | regulation of water loss via skin (GO:0033561) | 2.87763498 |
| 181 | sulfur amino acid catabolic process (GO:0000098) | 2.85379028 |
| 182 | acylglycerol homeostasis (GO:0055090) | 2.85247362 |
| 183 | triglyceride homeostasis (GO:0070328) | 2.85247362 |
| 184 | cholesterol homeostasis (GO:0042632) | 2.85146658 |
| 185 | alkaloid metabolic process (GO:0009820) | 2.84735848 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * TP63_17297297_ChIP-ChIP_HaCaT_Human | 8.21994111 |
| 2 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 5.32125579 |
| 3 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 4.93381289 |
| 4 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 3.80144243 |
| 5 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 3.56333391 |
| 6 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 3.31098908 |
| 7 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 3.19560832 |
| 8 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.09625311 |
| 9 | GATA6_25053715_ChIP-Seq_YYC3_Human | 3.06518280 |
| 10 | * SOX2_20726797_ChIP-Seq_SW620_Human | 2.83729485 |
| 11 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.76840348 |
| 12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.33837211 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.23528605 |
| 14 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.21132454 |
| 15 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 2.18780384 |
| 16 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.15448354 |
| 17 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.15046411 |
| 18 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.11341863 |
| 19 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.00017820 |
| 20 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.96527008 |
| 21 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.91180748 |
| 22 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.90366857 |
| 23 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.87667775 |
| 24 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.86904166 |
| 25 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.83819118 |
| 26 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.83016322 |
| 27 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.82100002 |
| 28 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.81131897 |
| 29 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.75171060 |
| 30 | ATF3_27146783_Chip-Seq_COLON_Human | 1.75002173 |
| 31 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.74964359 |
| 32 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.74933445 |
| 33 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.72203008 |
| 34 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.71613880 |
| 35 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.70017183 |
| 36 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.69477839 |
| 37 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.68052419 |
| 38 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.63422897 |
| 39 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.60008786 |
| 40 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.58591823 |
| 41 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.58004123 |
| 42 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.56195892 |
| 43 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.54831530 |
| 44 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.54172488 |
| 45 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.54172488 |
| 46 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.50310539 |
| 47 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.49773494 |
| 48 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.47958168 |
| 49 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.46639172 |
| 50 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.43722838 |
| 51 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.42492265 |
| 52 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.42431045 |
| 53 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.42272577 |
| 54 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.41609050 |
| 55 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.41514369 |
| 56 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.41090766 |
| 57 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.41002790 |
| 58 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.39677923 |
| 59 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.37158182 |
| 60 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.36993748 |
| 61 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.34663732 |
| 62 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.34528840 |
| 63 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.30739424 |
| 64 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.28053667 |
| 65 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.27747339 |
| 66 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.26491778 |
| 67 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.26169170 |
| 68 | * SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.25725821 |
| 69 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.21728944 |
| 70 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.20657195 |
| 71 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.20111160 |
| 72 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.18978545 |
| 73 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.18411690 |
| 74 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.16695604 |
| 75 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.16000577 |
| 76 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.14960663 |
| 77 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.14919363 |
| 78 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.14613230 |
| 79 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.13438110 |
| 80 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.11591609 |
| 81 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.11079183 |
| 82 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.10904362 |
| 83 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.09132493 |
| 84 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.07515989 |
| 85 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.03654537 |
| 86 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.02491401 |
| 87 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.02466542 |
| 88 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.99530379 |
| 89 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.98475845 |
| 90 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.97394567 |
| 91 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.97151899 |
| 92 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.96439944 |
| 93 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.95604164 |
| 94 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.95101582 |
| 95 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.94585517 |
| 96 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.94089582 |
| 97 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.93326186 |
| 98 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.92287212 |
| 99 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.90278118 |
| 100 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.90263511 |
| 101 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.90246414 |
| 102 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.89881476 |
| 103 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.89795954 |
| 104 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.89505330 |
| 105 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.89322308 |
| 106 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.89320887 |
| 107 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.88685759 |
| 108 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.87868249 |
| 109 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.86243947 |
| 110 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.85939422 |
| 111 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.85754447 |
| 112 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.85577338 |
| 113 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.85265872 |
| 114 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.84934909 |
| 115 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.84706829 |
| 116 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.83546027 |
| 117 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.82594764 |
| 118 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.81580619 |
| 119 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.81169839 |
| 120 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.79590999 |
| 121 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.79499068 |
| 122 | * SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.79103870 |
| 123 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.79009497 |
| 124 | SA1_27219007_Chip-Seq_Bcells_Human | 0.78997454 |
| 125 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.77719948 |
| 126 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.76857200 |
| 127 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.76564947 |
| 128 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.76503675 |
| 129 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.76435670 |
| 130 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.76203625 |
| 131 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.75862839 |
| 132 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.73674576 |
| 133 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.73521868 |
| 134 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.70090933 |
| 135 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.69631177 |
| 136 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.69615545 |
| 137 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.69422386 |
| 138 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.69289162 |
| 139 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.69059862 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010234_abnormal_vibrissa_follicle | 5.75944284 |
| 2 | MP0005360_urolithiasis | 5.05349246 |
| 3 | MP0004264_abnormal_extraembryonic_tissu | 4.44224266 |
| 4 | MP0009379_abnormal_foot_pigmentation | 4.26918004 |
| 5 | MP0001666_abnormal_nutrient_absorption | 3.94169370 |
| 6 | MP0000462_abnormal_digestive_system | 3.91358790 |
| 7 | MP0008004_abnormal_stomach_pH | 3.43814871 |
| 8 | MP0003195_calcinosis | 3.30609669 |
| 9 | MP0003866_abnormal_defecation | 3.20986683 |
| 10 | MP0000537_abnormal_urethra_morphology | 3.13045197 |
| 11 | MP0000490_abnormal_crypts_of | 2.84015990 |
| 12 | MP0003300_gastrointestinal_ulcer | 2.70824163 |
| 13 | MP0010155_abnormal_intestine_physiology | 2.64651227 |
| 14 | MP0001873_stomach_inflammation | 2.59574262 |
| 15 | MP0010352_gastrointestinal_tract_polyps | 2.45526756 |
| 16 | MP0002139_abnormal_hepatobiliary_system | 2.43221245 |
| 17 | MP0001663_abnormal_digestive_system | 2.40756630 |
| 18 | MP0005085_abnormal_gallbladder_physiolo | 2.36298640 |
| 19 | MP0005381_digestive/alimentary_phenotyp | 2.29748204 |
| 20 | MP0009840_abnormal_foam_cell | 2.10562077 |
| 21 | MP0003806_abnormal_nucleotide_metabolis | 2.10110906 |
| 22 | MP0001664_abnormal_digestion | 2.04604114 |
| 23 | MP0003693_abnormal_embryo_hatching | 2.03952032 |
| 24 | MP0000477_abnormal_intestine_morphology | 2.01935278 |
| 25 | MP0004019_abnormal_vitamin_homeostasis | 1.80536781 |
| 26 | MP0003252_abnormal_bile_duct | 1.80288840 |
| 27 | MP0002796_impaired_skin_barrier | 1.76359897 |
| 28 | MP0006054_spinal_hemorrhage | 1.73930305 |
| 29 | MP0001849_ear_inflammation | 1.69577581 |
| 30 | MP0002277_abnormal_respiratory_mucosa | 1.68380736 |
| 31 | MP0002098_abnormal_vibrissa_morphology | 1.66718869 |
| 32 | MP0003183_abnormal_peptide_metabolism | 1.66591111 |
| 33 | MP0000538_abnormal_urinary_bladder | 1.66291460 |
| 34 | MP0003453_abnormal_keratinocyte_physiol | 1.62647717 |
| 35 | MP0008875_abnormal_xenobiotic_pharmacok | 1.58406867 |
| 36 | MP0002118_abnormal_lipid_homeostasis | 1.45115933 |
| 37 | MP0010678_abnormal_skin_adnexa | 1.42860272 |
| 38 | MP0000470_abnormal_stomach_morphology | 1.34471833 |
| 39 | MP0003123_paternal_imprinting | 1.34125644 |
| 40 | MP0004957_abnormal_blastocyst_morpholog | 1.33625837 |
| 41 | MP0000613_abnormal_salivary_gland | 1.31781832 |
| 42 | MP0003315_abnormal_perineum_morphology | 1.30116625 |
| 43 | MP0000678_abnormal_parathyroid_gland | 1.28974409 |
| 44 | MP0009643_abnormal_urine_homeostasis | 1.27806221 |
| 45 | MP0001756_abnormal_urination | 1.26715868 |
| 46 | MP0005501_abnormal_skin_physiology | 1.24950861 |
| 47 | MP0002254_reproductive_system_inflammat | 1.24539123 |
| 48 | MP0008872_abnormal_physiological_respon | 1.24169431 |
| 49 | MP0001764_abnormal_homeostasis | 1.22106325 |
| 50 | MP0000566_synostosis | 1.20956742 |
| 51 | MP0003191_abnormal_cellular_cholesterol | 1.20298108 |
| 52 | MP0010329_abnormal_lipoprotein_level | 1.17231923 |
| 53 | MP0000467_abnormal_esophagus_morphology | 1.16418483 |
| 54 | MP0004043_abnormal_pH_regulation | 1.13628395 |
| 55 | MP0009780_abnormal_chondrocyte_physiolo | 1.13132902 |
| 56 | MP0001485_abnormal_pinna_reflex | 1.11470720 |
| 57 | MP0001216_abnormal_epidermal_layer | 1.07396293 |
| 58 | MP0003787_abnormal_imprinting | 1.06222251 |
| 59 | MP0003283_abnormal_digestive_organ | 1.05982577 |
| 60 | MP0003878_abnormal_ear_physiology | 1.04265066 |
| 61 | MP0005377_hearing/vestibular/ear_phenot | 1.04265066 |
| 62 | MP0005670_abnormal_white_adipose | 1.03451423 |
| 63 | MP0005409_darkened_coat_color | 1.01861536 |
| 64 | MP0005451_abnormal_body_composition | 1.00690981 |
| 65 | MP0002060_abnormal_skin_morphology | 1.00336045 |
| 66 | MP0003941_abnormal_skin_development | 0.99952014 |
| 67 | MP0002138_abnormal_hepatobiliary_system | 0.98205725 |
| 68 | MP0005365_abnormal_bile_salt | 0.97674525 |
| 69 | MP0003718_maternal_effect | 0.95111088 |
| 70 | MP0003119_abnormal_digestive_system | 0.94973727 |
| 71 | MP0002132_abnormal_respiratory_system | 0.94055112 |
| 72 | MP0005084_abnormal_gallbladder_morpholo | 0.93032765 |
| 73 | MP0009697_abnormal_copulation | 0.90089941 |
| 74 | MP0003186_abnormal_redox_activity | 0.89910355 |
| 75 | MP0005023_abnormal_wound_healing | 0.87690597 |
| 76 | MP0004782_abnormal_surfactant_physiolog | 0.87575009 |
| 77 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.87036013 |
| 78 | MP0001765_abnormal_ion_homeostasis | 0.85306867 |
| 79 | MP0005636_abnormal_mineral_homeostasis | 0.84500613 |
| 80 | MP0002876_abnormal_thyroid_physiology | 0.84044098 |
| 81 | MP0000579_abnormal_nail_morphology | 0.83339225 |
| 82 | MP0010386_abnormal_urinary_bladder | 0.80549591 |
| 83 | MP0009642_abnormal_blood_homeostasis | 0.78433759 |
| 84 | MP0010771_integument_phenotype | 0.77794606 |
| 85 | MP0005058_abnormal_lysosome_morphology | 0.77364073 |
| 86 | MP0003705_abnormal_hypodermis_morpholog | 0.75138378 |
| 87 | MP0004947_skin_inflammation | 0.75115336 |
| 88 | MP0005165_increased_susceptibility_to | 0.72615079 |
| 89 | MP0002909_abnormal_adrenal_gland | 0.72142220 |
| 90 | MP0000762_abnormal_tongue_morphology | 0.71906100 |
| 91 | MP0005220_abnormal_exocrine_pancreas | 0.71049533 |
| 92 | MP0000516_abnormal_urinary_system | 0.70755063 |
| 93 | MP0005367_renal/urinary_system_phenotyp | 0.70755063 |
| 94 | MP0008469_abnormal_protein_level | 0.70258561 |
| 95 | MP0005408_hypopigmentation | 0.70006810 |
| 96 | MP0004858_abnormal_nervous_system | 0.68886989 |
| 97 | MP0001845_abnormal_inflammatory_respons | 0.68518319 |
| 98 | MP0002822_catalepsy | 0.66903841 |
| 99 | MP0005248_abnormal_Harderian_gland | 0.66375967 |
| 100 | MP0005167_abnormal_blood-brain_barrier | 0.66167149 |
| 101 | MP0002078_abnormal_glucose_homeostasis | 0.65789984 |
| 102 | MP0005448_abnormal_energy_balance | 0.64841597 |
| 103 | MP0005166_decreased_susceptibility_to | 0.63512905 |
| 104 | MP0003879_abnormal_hair_cell | 0.63389956 |
| 105 | MP0002089_abnormal_postnatal_growth/wei | 0.63373771 |
| 106 | MP0005187_abnormal_penis_morphology | 0.63335445 |
| 107 | MP0004147_increased_porphyrin_level | 0.63175959 |
| 108 | MP0002166_altered_tumor_susceptibility | 0.62741813 |
| 109 | MP0009785_altered_susceptibility_to | 0.61725504 |
| 110 | MP0003953_abnormal_hormone_level | 0.61487881 |
| 111 | MP0002136_abnormal_kidney_physiology | 0.60334457 |
| 112 | MP0010030_abnormal_orbit_morphology | 0.59628059 |
| 113 | MP0000377_abnormal_hair_follicle | 0.59258482 |
| 114 | MP0000465_gastrointestinal_hemorrhage | 0.58027332 |
| 115 | MP0000598_abnormal_liver_morphology | 0.57766937 |
| 116 | MP0002971_abnormal_brown_adipose | 0.56520459 |
| 117 | MP0005083_abnormal_biliary_tract | 0.56495293 |
| 118 | MP0000604_amyloidosis | 0.55606398 |
| 119 | MP0005319_abnormal_enzyme/_coenzyme | 0.55016011 |
| 120 | MP0005164_abnormal_response_to | 0.55007879 |
| 121 | MP0003638_abnormal_response/metabolism_ | 0.53949924 |
| 122 | MP0005310_abnormal_salivary_gland | 0.53587762 |
| 123 | MP0005332_abnormal_amino_acid | 0.53396984 |
| 124 | MP0005376_homeostasis/metabolism_phenot | 0.53131925 |
| 125 | MP0002693_abnormal_pancreas_physiology | 0.52214385 |
| 126 | MP0003075_altered_response_to | 0.51913371 |
| 127 | MP0001191_abnormal_skin_condition | 0.51803577 |
| 128 | MP0002163_abnormal_gland_morphology | 0.51627449 |
| 129 | MP0001730_embryonic_growth_arrest | 0.51174911 |
| 130 | MP0000627_abnormal_mammary_gland | 0.51087880 |
| 131 | MP0003868_abnormal_feces_composition | 0.50593438 |
| 132 | MP0000609_abnormal_liver_physiology | 0.48921354 |
| 133 | MP0003329_amyloid_beta_deposits | 0.48226064 |
| 134 | MP0001944_abnormal_pancreas_morphology | 0.45719070 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ileus (HP:0002595) | 7.34981094 |
| 2 | Right ventricular cardiomyopathy (HP:0011663) | 5.93717036 |
| 3 | Ventricular fibrillation (HP:0001663) | 5.88116712 |
| 4 | Complement deficiency (HP:0004431) | 5.68431751 |
| 5 | Deep venous thrombosis (HP:0002625) | 5.62041470 |
| 6 | Systemic lupus erythematosus (HP:0002725) | 5.43210736 |
| 7 | Abnormality of complement system (HP:0005339) | 4.88398562 |
| 8 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.75775951 |
| 9 | Abnormal hemoglobin (HP:0011902) | 4.58928913 |
| 10 | Glomerulonephritis (HP:0000099) | 4.53088351 |
| 11 | Congenital sensorineural hearing impairment (HP:0008527) | 4.47632085 |
| 12 | Prolonged partial thromboplastin time (HP:0003645) | 4.41075223 |
| 13 | Pustule (HP:0200039) | 4.28835852 |
| 14 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.01386728 |
| 15 | Hemorrhage of the eye (HP:0011885) | 3.89082166 |
| 16 | Vascular calcification (HP:0004934) | 3.79506213 |
| 17 | Xanthomatosis (HP:0000991) | 3.66867502 |
| 18 | Onycholysis (HP:0001806) | 3.65402802 |
| 19 | Pili torti (HP:0003777) | 3.48721383 |
| 20 | Cheilitis (HP:0100825) | 3.45464061 |
| 21 | Abdominal distention (HP:0003270) | 3.44765006 |
| 22 | Woolly hair (HP:0002224) | 3.44489347 |
| 23 | Rectal prolapse (HP:0002035) | 3.44064003 |
| 24 | Trismus (HP:0000211) | 3.43064090 |
| 25 | Villous atrophy (HP:0011473) | 3.42867341 |
| 26 | Abnormality of small intestinal villus morphology (HP:0011472) | 3.42867341 |
| 27 | Micronodular cirrhosis (HP:0001413) | 3.35504755 |
| 28 | Conjugated hyperbilirubinemia (HP:0002908) | 3.32961946 |
| 29 | Abnormal biliary tract morphology (HP:0012440) | 3.30907483 |
| 30 | Malnutrition (HP:0004395) | 3.26140486 |
| 31 | Nephritis (HP:0000123) | 3.22926418 |
| 32 | Cardiovascular calcification (HP:0011915) | 3.22612595 |
| 33 | Steatorrhea (HP:0002570) | 3.21576414 |
| 34 | Abnormality of the gastric mucosa (HP:0004295) | 3.12270458 |
| 35 | Biliary tract neoplasm (HP:0100574) | 3.12008103 |
| 36 | Fragile nails (HP:0001808) | 3.11360634 |
| 37 | Ankyloglossia (HP:0010296) | 3.05685431 |
| 38 | Abnormality of urine glucose concentration (HP:0011016) | 3.05379736 |
| 39 | Glycosuria (HP:0003076) | 3.05379736 |
| 40 | Abnormality of proline metabolism (HP:0010907) | 2.98747451 |
| 41 | Hydroxyprolinuria (HP:0003080) | 2.98747451 |
| 42 | Milia (HP:0001056) | 2.97499323 |
| 43 | Reticulocytopenia (HP:0001896) | 2.97156524 |
| 44 | Hypolipoproteinemia (HP:0010981) | 2.96742744 |
| 45 | Flat acetabular roof (HP:0003180) | 2.94684692 |
| 46 | Decreased circulating renin level (HP:0003351) | 2.89893329 |
| 47 | Syncope (HP:0001279) | 2.87701624 |
| 48 | Palpitations (HP:0001962) | 2.84361556 |
| 49 | Joint hemorrhage (HP:0005261) | 2.83590318 |
| 50 | Amniotic constriction ring (HP:0009775) | 2.81591480 |
| 51 | Abnormality of placental membranes (HP:0011409) | 2.81591480 |
| 52 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.81449283 |
| 53 | Plantar hyperkeratosis (HP:0007556) | 2.79968726 |
| 54 | Hyperactive renin-angiotensin system (HP:0000841) | 2.79681123 |
| 55 | Colon cancer (HP:0003003) | 2.75604792 |
| 56 | Alkalosis (HP:0001948) | 2.74991679 |
| 57 | Abnormality of renin-angiotensin system (HP:0000847) | 2.73257689 |
| 58 | Lipid accumulation in hepatocytes (HP:0006561) | 2.71092558 |
| 59 | Autoimmune hemolytic anemia (HP:0001890) | 2.68124792 |
| 60 | Abnormal tarsal ossification (HP:0008369) | 2.67206192 |
| 61 | Microretrognathia (HP:0000308) | 2.67101259 |
| 62 | Focal segmental glomerulosclerosis (HP:0000097) | 2.64736917 |
| 63 | Hyperammonemia (HP:0001987) | 2.62906754 |
| 64 | Increased hepatocellular lipid droplets (HP:0006565) | 2.62409847 |
| 65 | Hypoglycemic coma (HP:0001325) | 2.60992217 |
| 66 | Fragile skin (HP:0001030) | 2.60882584 |
| 67 | Curly hair (HP:0002212) | 2.60091562 |
| 68 | Abnormality of chloride homeostasis (HP:0011422) | 2.58849575 |
| 69 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.57694826 |
| 70 | Hyperparathyroidism (HP:0000843) | 2.56932794 |
| 71 | Premature loss of primary teeth (HP:0006323) | 2.54968641 |
| 72 | Posterior subcapsular cataract (HP:0007787) | 2.52862076 |
| 73 | Abnormality of the common coagulation pathway (HP:0010990) | 2.51812942 |
| 74 | Increased muscle lipid content (HP:0009058) | 2.51583194 |
| 75 | Autoimmune thrombocytopenia (HP:0001973) | 2.51002178 |
| 76 | Increased intramyocellular lipid droplets (HP:0012240) | 2.50737954 |
| 77 | Hyperphosphaturia (HP:0003109) | 2.49789571 |
| 78 | Glomerulosclerosis (HP:0000096) | 2.45739686 |
| 79 | Poikiloderma (HP:0001029) | 2.45467117 |
| 80 | Hepatic necrosis (HP:0002605) | 2.44496597 |
| 81 | Macrocytic anemia (HP:0001972) | 2.43237527 |
| 82 | Potter facies (HP:0002009) | 2.43047926 |
| 83 | Facial shape deformation (HP:0011334) | 2.43047926 |
| 84 | Uterine neoplasm (HP:0010784) | 2.43002478 |
| 85 | Spontaneous abortion (HP:0005268) | 2.42067440 |
| 86 | Dehydration (HP:0001944) | 2.41080186 |
| 87 | Atrophic scars (HP:0001075) | 2.39132347 |
| 88 | Hypobetalipoproteinemia (HP:0003563) | 2.37578177 |
| 89 | Ridged nail (HP:0001807) | 2.37286715 |
| 90 | Ventricular arrhythmia (HP:0004308) | 2.36310563 |
| 91 | Hypotension (HP:0002615) | 2.35512254 |
| 92 | Gout (HP:0001997) | 2.34165005 |
| 93 | Abnormality of carpal bone ossification (HP:0006257) | 2.33957907 |
| 94 | Hepatocellular necrosis (HP:0001404) | 2.33825138 |
| 95 | Mitochondrial inheritance (HP:0001427) | 2.32973092 |
| 96 | Gastrointestinal dysmotility (HP:0002579) | 2.31859949 |
| 97 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.27112945 |
| 98 | Late onset (HP:0003584) | 2.26032659 |
| 99 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 2.23531657 |
| 100 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.23362731 |
| 101 | Hypercholesterolemia (HP:0003124) | 2.22135149 |
| 102 | Hypercortisolism (HP:0001578) | 2.21531236 |
| 103 | Symptomatic seizures (HP:0011145) | 2.20748544 |
| 104 | Neoplasm of the small intestine (HP:0100833) | 2.19926437 |
| 105 | Neoplasm of the rectum (HP:0100743) | 2.17588124 |
| 106 | Increased purine levels (HP:0004368) | 2.16924266 |
| 107 | Hyperuricemia (HP:0002149) | 2.16924266 |
| 108 | Malignant gastrointestinal tract tumors (HP:0006749) | 2.16710328 |
| 109 | Gastrointestinal carcinoma (HP:0002672) | 2.16710328 |
| 110 | Goiter (HP:0000853) | 2.16351589 |
| 111 | Pigmentary retinal degeneration (HP:0001146) | 2.16168514 |
| 112 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.15260961 |
| 113 | Abnormality of glycine metabolism (HP:0010895) | 2.15260961 |
| 114 | Abnormality of nucleobase metabolism (HP:0010932) | 2.13939132 |
| 115 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.13154528 |
| 116 | Widely patent fontanelles and sutures (HP:0004492) | 2.13102012 |
| 117 | Abnormal blistering of the skin (HP:0008066) | 2.10521515 |
| 118 | Fat malabsorption (HP:0002630) | 2.10366772 |
| 119 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.09215795 |
| 120 | Acanthocytosis (HP:0001927) | 2.08885218 |
| 121 | Rickets (HP:0002748) | 2.08318375 |
| 122 | 11 pairs of ribs (HP:0000878) | 2.08217431 |
| 123 | Exocrine pancreatic insufficiency (HP:0001738) | 2.07392136 |
| 124 | Hyperlipoproteinemia (HP:0010980) | 2.06413943 |
| 125 | Hyperglycemia (HP:0003074) | 2.05599532 |
| 126 | Abnormality of vitamin B metabolism (HP:0004340) | 2.03957043 |
| 127 | Abnormal hair laboratory examination (HP:0003328) | 2.02959161 |
| 128 | Hyperglycinuria (HP:0003108) | 2.02424946 |
| 129 | Neoplasm of the colon (HP:0100273) | 2.01733758 |
| 130 | Proximal tubulopathy (HP:0000114) | 2.01542275 |
| 131 | Abnormal urine phosphate concentration (HP:0012599) | 2.01518876 |
| 132 | Exertional dyspnea (HP:0002875) | 2.01338923 |
| 133 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.01320775 |
| 134 | Xerostomia (HP:0000217) | 2.00315657 |
| 135 | Abnormal sex determination (HP:0012244) | 1.99648654 |
| 136 | Sex reversal (HP:0012245) | 1.99648654 |
| 137 | Increased CSF lactate (HP:0002490) | 1.98803102 |
| 138 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.98651714 |
| 139 | Metabolic alkalosis (HP:0200114) | 1.95177417 |
| 140 | Periodontitis (HP:0000704) | 1.94636477 |
| 141 | Rough bone trabeculation (HP:0100670) | 1.94151059 |
| 142 | Abnormality of purine metabolism (HP:0004352) | 1.93884439 |
| 143 | Azoospermia (HP:0000027) | 1.93408823 |
| 144 | Hypoalphalipoproteinemia (HP:0003233) | 1.92779763 |
| 145 | Abnormality of oral frenula (HP:0000190) | 1.92640167 |
| 146 | Hypoglycemic seizures (HP:0002173) | 1.92324927 |
| 147 | Abnormal number of erythroid precursors (HP:0012131) | 1.91814899 |
| 148 | Hypoplasia of the uterus (HP:0000013) | 1.91738617 |
| 149 | Purpura (HP:0000979) | 1.90939775 |
| 150 | Metabolic acidosis (HP:0001942) | 1.90665294 |
| 151 | Epidermoid cyst (HP:0200040) | 1.90519964 |
| 152 | Intrahepatic cholestasis (HP:0001406) | 1.90276335 |
| 153 | Abnormality of vitamin metabolism (HP:0100508) | 1.88194455 |
| 154 | Chronic diarrhea (HP:0002028) | 1.87047321 |
| 155 | Acute encephalopathy (HP:0006846) | 1.86890633 |
| 156 | Hyponatremia (HP:0002902) | 1.85940622 |
| 157 | Abnormal pancreas size (HP:0012094) | 1.85820426 |
| 158 | Gingival bleeding (HP:0000225) | 1.83292415 |
| 159 | Pancreatitis (HP:0001733) | 1.83144679 |
| 160 | Hyperaldosteronism (HP:0000859) | 1.79071889 |
| 161 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.78717017 |
| 162 | Hepatocellular carcinoma (HP:0001402) | 1.78329198 |
| 163 | Renal tubular acidosis (HP:0001947) | 1.77972315 |
| 164 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.77165498 |
| 165 | Skin nodule (HP:0200036) | 1.74205189 |
| 166 | Cerebral palsy (HP:0100021) | 1.74093949 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | LMTK2 | 5.67683413 |
| 2 | EPHA2 | 5.59562580 |
| 3 | FRK | 4.82480206 |
| 4 | MST1R | 4.00102998 |
| 5 | MST4 | 3.96325547 |
| 6 | NME1 | 3.16911177 |
| 7 | MAP2K2 | 3.15714722 |
| 8 | PBK | 2.62559647 |
| 9 | FGFR4 | 2.55811133 |
| 10 | PRKG2 | 2.50011064 |
| 11 | MAP2K6 | 2.44059995 |
| 12 | MAP3K2 | 2.26483344 |
| 13 | ACVR1B | 2.18814693 |
| 14 | NUAK1 | 2.16706210 |
| 15 | TESK1 | 2.01899065 |
| 16 | EPHB2 | 1.81354581 |
| 17 | MAP3K12 | 1.79942425 |
| 18 | RIPK1 | 1.66672555 |
| 19 | TLK1 | 1.61672392 |
| 20 | PAK4 | 1.60841339 |
| 21 | TTK | 1.58778309 |
| 22 | FGFR3 | 1.53195642 |
| 23 | MAP3K3 | 1.52992898 |
| 24 | SIK1 | 1.50045016 |
| 25 | STK24 | 1.46886043 |
| 26 | MAP3K11 | 1.39974565 |
| 27 | PTK6 | 1.39186652 |
| 28 | FER | 1.37648939 |
| 29 | MET | 1.36576013 |
| 30 | RPS6KB2 | 1.27275073 |
| 31 | PTK2 | 1.22957617 |
| 32 | EIF2AK1 | 1.20001270 |
| 33 | STK39 | 1.18659942 |
| 34 | NME2 | 1.16149623 |
| 35 | PIM2 | 1.13647971 |
| 36 | PRKCI | 1.08375968 |
| 37 | BUB1 | 1.07662058 |
| 38 | MYLK | 1.06929198 |
| 39 | GRK6 | 1.05601400 |
| 40 | MAP2K1 | 1.03224596 |
| 41 | ERBB3 | 1.01732251 |
| 42 | ERBB2 | 1.00880556 |
| 43 | ICK | 0.96709165 |
| 44 | AURKB | 0.94189112 |
| 45 | NEK9 | 0.91336328 |
| 46 | MAPK15 | 0.86113409 |
| 47 | CDC42BPA | 0.81876478 |
| 48 | TRIB3 | 0.78500891 |
| 49 | ERN1 | 0.77221836 |
| 50 | MAP3K8 | 0.76525793 |
| 51 | TAOK3 | 0.75746677 |
| 52 | IRAK3 | 0.74422780 |
| 53 | EPHA3 | 0.73683170 |
| 54 | MAP3K9 | 0.72594281 |
| 55 | STK38L | 0.72254909 |
| 56 | PHKG1 | 0.71831045 |
| 57 | PHKG2 | 0.71831045 |
| 58 | IRAK1 | 0.69465937 |
| 59 | WNK4 | 0.68774837 |
| 60 | CDK19 | 0.64568163 |
| 61 | TYK2 | 0.64442265 |
| 62 | MAP3K1 | 0.64069040 |
| 63 | BMX | 0.63269656 |
| 64 | PDPK1 | 0.62608643 |
| 65 | SMG1 | 0.62418490 |
| 66 | MAP3K10 | 0.61882735 |
| 67 | EPHB1 | 0.61719770 |
| 68 | SCYL2 | 0.59784078 |
| 69 | LATS1 | 0.59140052 |
| 70 | PASK | 0.59036385 |
| 71 | LIMK1 | 0.57996437 |
| 72 | NLK | 0.56988554 |
| 73 | PIK3CA | 0.56457607 |
| 74 | MAPKAPK3 | 0.55274467 |
| 75 | CAMK2D | 0.54681751 |
| 76 | GRK1 | 0.52675222 |
| 77 | CAMK2B | 0.52488471 |
| 78 | CAMK2G | 0.51320815 |
| 79 | DYRK1B | 0.51311666 |
| 80 | BMPR1B | 0.51144800 |
| 81 | KSR2 | 0.49061012 |
| 82 | RPS6KA4 | 0.47862035 |
| 83 | CDK6 | 0.47583936 |
| 84 | MAP3K13 | 0.47445156 |
| 85 | MATK | 0.43026933 |
| 86 | NEK1 | 0.42026594 |
| 87 | LRRK2 | 0.41971074 |
| 88 | MELK | 0.41163028 |
| 89 | PDK2 | 0.41158823 |
| 90 | BCR | 0.40763917 |
| 91 | MAP3K7 | 0.39887049 |
| 92 | ERBB4 | 0.39758418 |
| 93 | PLK1 | 0.38838877 |
| 94 | BMPR2 | 0.38747100 |
| 95 | INSRR | 0.38352755 |
| 96 | PRKAA1 | 0.37575134 |
| 97 | PRKACG | 0.36896969 |
| 98 | PDK1 | 0.35825242 |
| 99 | PRKCZ | 0.34597954 |
| 100 | OXSR1 | 0.34419521 |
| 101 | BLK | 0.33389040 |
| 102 | FGR | 0.33307989 |
| 103 | STK10 | 0.33024302 |
| 104 | PAK1 | 0.32801830 |
| 105 | TAOK1 | 0.32641900 |
| 106 | PRKD3 | 0.31964628 |
| 107 | MAPK11 | 0.31110585 |
| 108 | PAK3 | 0.30588445 |
| 109 | DDR2 | 0.30572294 |
| 110 | PDGFRA | 0.29645644 |
| 111 | SRC | 0.29102618 |
| 112 | VRK1 | 0.28985270 |
| 113 | TESK2 | 0.28825912 |
| 114 | CDK12 | 0.27312691 |
| 115 | FGFR2 | 0.27305675 |
| 116 | AKT3 | 0.26966397 |
| 117 | PKN2 | 0.26069877 |
| 118 | CSNK1A1 | 0.25833340 |
| 119 | MAP3K14 | 0.25790118 |
| 120 | CHUK | 0.24871726 |
| 121 | IRAK4 | 0.23702844 |
| 122 | IRAK2 | 0.22975425 |
| 123 | PRKCA | 0.22906269 |
| 124 | FGFR1 | 0.22448043 |
| 125 | DAPK3 | 0.22072644 |
| 126 | HIPK2 | 0.22048904 |
| 127 | IGF1R | 0.21894647 |
| 128 | PRKCQ | 0.21299747 |
| 129 | DAPK1 | 0.21115374 |
| 130 | PRKCE | 0.20304969 |
| 131 | CDK7 | 0.20231899 |
| 132 | STK38 | 0.19545682 |
| 133 | STK3 | 0.18476488 |
| 134 | TBK1 | 0.18383128 |
| 135 | AURKA | 0.17962074 |
| 136 | CSNK1E | 0.17484603 |
| 137 | ARAF | 0.17433968 |
| 138 | BRAF | 0.16314712 |
| 139 | PRKAA2 | 0.16121319 |
| 140 | PDK3 | 0.16076131 |
| 141 | PDK4 | 0.16076131 |
| 142 | STK4 | 0.15583168 |
| 143 | ZAP70 | 0.15232877 |
| 144 | PRKCD | 0.14943427 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fat digestion and absorption_Homo sapiens_hsa04975 | 4.16927574 |
| 2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.97191924 |
| 3 | Mineral absorption_Homo sapiens_hsa04978 | 3.55229380 |
| 4 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.31120755 |
| 5 | Ribosome_Homo sapiens_hsa03010 | 3.10372630 |
| 6 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.82670692 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.63810044 |
| 8 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.59733309 |
| 9 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.55486376 |
| 10 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.55324135 |
| 11 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 2.30021227 |
| 12 | Renin-angiotensin system_Homo sapiens_hsa04614 | 2.25360286 |
| 13 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.19837478 |
| 14 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.18547245 |
| 15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.17473969 |
| 16 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.09137787 |
| 17 | Histidine metabolism_Homo sapiens_hsa00340 | 2.08146142 |
| 18 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.02962965 |
| 19 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.95438580 |
| 20 | Parkinsons disease_Homo sapiens_hsa05012 | 1.92911606 |
| 21 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.86790230 |
| 22 | Galactose metabolism_Homo sapiens_hsa00052 | 1.80200706 |
| 23 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.79972772 |
| 24 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.79489076 |
| 25 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.75566593 |
| 26 | * Glutathione metabolism_Homo sapiens_hsa00480 | 1.75139448 |
| 27 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.73589752 |
| 28 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.64949401 |
| 29 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.63260815 |
| 30 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.52250757 |
| 31 | Alzheimers disease_Homo sapiens_hsa05010 | 1.50801907 |
| 32 | Huntingtons disease_Homo sapiens_hsa05016 | 1.49508059 |
| 33 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.41256044 |
| 34 | Tight junction_Homo sapiens_hsa04530 | 1.39372674 |
| 35 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.37079334 |
| 36 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.36247838 |
| 37 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.30793881 |
| 38 | Bile secretion_Homo sapiens_hsa04976 | 1.30233413 |
| 39 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.29284870 |
| 40 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.26696756 |
| 41 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.21956385 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.20214936 |
| 43 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.20109518 |
| 44 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.16629115 |
| 45 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.14752094 |
| 46 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.10428272 |
| 47 | Bladder cancer_Homo sapiens_hsa05219 | 1.10379497 |
| 48 | Peroxisome_Homo sapiens_hsa04146 | 1.08771233 |
| 49 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.08634658 |
| 50 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.06133477 |
| 51 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.00959028 |
| 52 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.00067443 |
| 53 | Retinol metabolism_Homo sapiens_hsa00830 | 0.99353889 |
| 54 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.98664730 |
| 55 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.97623950 |
| 56 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.96493236 |
| 57 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.92023936 |
| 58 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.91177998 |
| 59 | Proteasome_Homo sapiens_hsa03050 | 0.89396393 |
| 60 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.89393035 |
| 61 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.88574521 |
| 62 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.88125265 |
| 63 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.86496982 |
| 64 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.86205654 |
| 65 | Protein export_Homo sapiens_hsa03060 | 0.82254336 |
| 66 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.81474032 |
| 67 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.79320160 |
| 68 | Carbon metabolism_Homo sapiens_hsa01200 | 0.79184208 |
| 69 | Hepatitis C_Homo sapiens_hsa05160 | 0.77705600 |
| 70 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.77397173 |
| 71 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.74616201 |
| 72 | Thyroid cancer_Homo sapiens_hsa05216 | 0.72234092 |
| 73 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.70796787 |
| 74 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.67320599 |
| 75 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.63379337 |
| 76 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.62143148 |
| 77 | Metabolic pathways_Homo sapiens_hsa01100 | 0.61193061 |
| 78 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.60984317 |
| 79 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.58784007 |
| 80 | Adherens junction_Homo sapiens_hsa04520 | 0.57914665 |
| 81 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.57410251 |
| 82 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.56196098 |
| 83 | * Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.54062049 |
| 84 | Other glycan degradation_Homo sapiens_hsa00511 | 0.47424492 |
| 85 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.45033101 |
| 86 | Purine metabolism_Homo sapiens_hsa00230 | 0.44771591 |
| 87 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.44299414 |
| 88 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.42287079 |
| 89 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.40745736 |
| 90 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.40356515 |
| 91 | * Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.40054593 |
| 92 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.40034334 |
| 93 | Sulfur relay system_Homo sapiens_hsa04122 | 0.39302528 |
| 94 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.39068622 |
| 95 | Insulin resistance_Homo sapiens_hsa04931 | 0.37041096 |
| 96 | Salmonella infection_Homo sapiens_hsa05132 | 0.36975901 |
| 97 | Mismatch repair_Homo sapiens_hsa03430 | 0.36517176 |
| 98 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.36186263 |
| 99 | Pertussis_Homo sapiens_hsa05133 | 0.35025030 |
| 100 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.34408544 |
| 101 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.32731259 |
| 102 | Legionellosis_Homo sapiens_hsa05134 | 0.32610701 |
| 103 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.32076378 |
| 104 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.32050991 |
| 105 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.31931962 |
| 106 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.31867277 |
| 107 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.30876387 |
| 108 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.29363285 |
| 109 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.28465998 |
| 110 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.28276309 |
| 111 | Prion diseases_Homo sapiens_hsa05020 | 0.28200586 |
| 112 | RNA polymerase_Homo sapiens_hsa03020 | 0.28074822 |
| 113 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.26318343 |
| 114 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.25094222 |
| 115 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.24558229 |
| 116 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.24507519 |
| 117 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.22510540 |
| 118 | Influenza A_Homo sapiens_hsa05164 | 0.20735834 |
| 119 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.19245614 |
| 120 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.17450507 |
| 121 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.16271682 |
| 122 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.15995357 |
| 123 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.14924865 |
| 124 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.13074246 |
| 125 | ABC transporters_Homo sapiens_hsa02010 | 0.12355525 |
| 126 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.12185490 |
| 127 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.10368101 |
| 128 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.09267370 |
| 129 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.06983023 |
| 130 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.04147808 |
| 131 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.02402852 |
| 132 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.02249563 |

